More recently, several brain tumor types including IDH-mutant gliomas have been found to be sensitive to inhibitors of dihydroorotate dehydrogenase (DHODH), an enzyme in the de novo pyrimidine synthesis pathway53,85,86. Here, IDH2 is linked to brain neoplasm.